IL-17RA signaling reduces inflammation and mortality during trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils

PLoS Pathogens

Volumn 8, Issue 4, 2012, Pages

  Boari, Jimena Tosello ^a   Vesely, María Carolina Amezcua ^a   Bermejo, Daniela Andrea ^a   Ramello, Maria Cecilia ^a   Montes, Carolina Lucía ^a   Cejas, Hugo ^a   Gruppi, Adriana ^a   Rodríguez, Eva Virginia Acosta ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17 RECEPTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL TRANSFER; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIVER; LIVER INJURY; LYMPHOCYTE PROLIFERATION; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITEMIA; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPLEEN; SURVIVAL; T LYMPHOCYTE;

ANIMALS; CELLS, CULTURED; CHAGAS DISEASE; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION; SPLEEN; TRYPANOSOMA CRUZI;

MUS; TRYPANOSOMA CRUZI;

EID: 84861204482     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002658     Document Type: Article

References (67)

1. Iwakura Y, Ishigame H, Saijo S, Nakae S, (2011) Functional specialization of interleukin-17 family members. Immunity 34: 149-162.
2. Kolls JK, Linden A, (2004) Interleukin-17 family members and inflammation. Immunity 21: 467-476.
3. Liang SC, Long AJ, Bennett F, Whitters MJ, Karim R, et al. (2007) An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 179: 7791-7799.
4. Weaver CT, Hatton RD, Mangan PR, Harrington LE, (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25: 821-852.
5. Ouyang W, Kolls JK, Zheng Y, (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454-467.
6. Xu S, Cao X, (2010) Interleukin-17 and its expanding biological functions. Cell Mol Immunol 7: 164-174.
7. Li H, Chen J, Huang A, Stinson J, Heldens S, et al. (2000) Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci U S A 97: 773-778.
8. Shi Y, Ullrich SJ, Zhang J, Connolly K, Grzegorzewski KJ, et al. (2000) A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem 275: 19167-19176.
9. Starnes T, Broxmeyer HE, Robertson MJ, Hromas R, (2002) Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 169: 642-646.
10. Yamaguchi Y, Fujio K, Shoda H, Okamoto A, Tsuno NH, et al. (2007) IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis. J Immunol 179: 7128-7136.
11. Zaph C, Du Y, Saenz SA, Nair MG, Perrigoue JG, et al. (2008) Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med 205: 2191-2198.
12. Caruso R, Stolfi C, Sarra M, Rizzo A, Fantini MC, et al. (2009) Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3. Blood 113: 3512-3519.
13. Kleinschek MA, Owyang AM, Joyce-Shaikh B, Langrish CL, Chen Y, et al. (2007) IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 204: 161-170.
14. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, et al. (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15: 985-995.
15. Zhao A, Urban JF Jr, Sun R, Stiltz J, Morimoto M, et al. (2010) Critical role of IL-25 in nematode infection-induced alterations in intestinal function. J Immunol 185: 6921-6929.
16. Tamachi T, Maezawa Y, Ikeda K, Kagami S, Hatano M, et al. (2006) IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. J Allergy Clin Immunol 118: 606-614.
17. Gaffen SL, (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9: 556-567.
18. Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, et al. (2006) Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 177: 36-39.
19. Rickel EA, Siegel LA, Yoon BR, Rottman JB, Kugler DG, et al. (2008) Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol 181: 4299-4310.
20. Chang SH, Reynolds JM, Pappu BP, Chen G, Martinez GJ, et al. (2011) Interleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor E. Immunity 35: 611-621.
21. Song X, Zhu S, Shi P, Liu Y, Shi Y, et al. (2011) IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol 12: 1151-1158.
22. Brener Z, Gazzinelli RT, (1997) Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 114: 103-110.
23. Umekita LF, Mota I, (2000) How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi? Braz J Med Biol Res 33: 253-258.
24. Golden JM, Tarleton RL, (1991) Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity. Exp Parasitol 72: 391-402.
25. McCabe RE, Meagher SG, Mullins BT, (1991) Endogenous interferon-gamma, macrophage activation, and murine host defense against acute infection with Trypanosoma cruzi. J Infect Dis 163: 912-915.
26. Torrico F, Heremans H, Rivera MT, Van Marck E, Billiau A, et al. (1991) Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol 146: 3626-3632.
27. Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, et al. (2001) Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun 17: 99-107.
28. Fiuza JA, Fujiwara RT, Gomes JA, Rocha MO, Chaves AT, et al. (2009) Profile of central and effector memory T cells in the progression of chronic human chagas disease. PLoS Negl Trop Dis 3: e512.
29. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, et al. (2003) Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 71: 1185-1193.
30. Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, et al. (2005) Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun 73: 7960-7966.
31. Hamano S, Himeno K, Miyazaki Y, Ishii K, Yamanaka A, et al. (2003) WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19: 657-667.
32. Holscher C, Mohrs M, Dai WJ, Kohler G, Ryffel B, et al. (2000) Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect Immun 68: 4075-4083.
33. Hunter CA, Ellis-Neyes LA, Slifer T, Kanaly S, Grunig G, et al. (1997) IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 158: 3311-3316.
34. Guiton R, Vasseur V, Charron S, Arias MT, Van Langendonck N, et al. (2010) Interleukin 17 receptor signaling is deleterious during Toxoplasma gondii infection in susceptible BL6 mice. J Infect Dis 202: 427-435.
35. Kelly MN, Kolls JK, Happel K, Schwartzman JD, Schwarzenberger P, et al. (2005) Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 73: 617-621.
36. da Matta Guedes PM, Gutierrez FR, Maia FL, Milanezi CM, Silva GK, et al. (2010) IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl Trop Dis 4: e604.
37. Miyazaki Y, Hamano S, Wang S, Shimanoe Y, Iwakura Y, et al. (2010) IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. J Immunol 185: 1150-1157.
38. Cua DJ, Tato CM, (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10: 479-489.
39. Moser B, Clark-Lewis I, Zwahlen R, Baggiolini M, (1990) Neutrophil-activating properties of the melanoma growth-stimulatory activity. J Exp Med 171: 1797-1802.
40. Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, et al. (1989) Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci U S A 86: 612-616.
41. Onishi RM, Gaffen SL, (2010) Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129: 311-321.
42. Luster AD, Unkeless JC, Ravetch JV, (1985) Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315: 672-676.
43. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, et al. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194: 519-527.
44. Mantovani A, Cassatella MA, Costantini C, Jaillon S, (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11: 519-531.
45. Matsuzaki G, Umemura M, (2007) Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 51: 1139-1147.
46. Owyang AM, Zaph C, Wilson EH, Guild KJ, McClanahan T, et al. (2006) Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med 203: 843-849.
47. O'Connor W Jr, Zenewicz LA, Flavell RA, (2010) The dual nature of T(H)17 cells: shifting the focus to function. Nat Immunol 11: 471-476.
48. Yi T, Zhao D, Lin CL, Zhang C, Chen Y, et al. (2008) Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 112: 2101-2110.
49. O'Connor W Jr, Kamanaka M, Booth CJ, Town T, Nakae S, et al. (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 10: 603-609.
50. Monteleone G, Pallone F, Macdonald TT, (2010) Interleukin-25: a two-edged sword in the control of immune-inflammatory responses. Cytokine Growth Factor Rev 21: 471-475.
51. Sadik CD, Kim ND, Luster AD, (2011) Neutrophils cascading their way to inflammation. Trends Immunol 32: 452-460.
52. Chen L, Watanabe T, Watanabe H, Sendo F, (2001) Neutrophil depletion exacerbates experimental Chagas' disease in BALB/c, but protects C57BL/6 mice through modulating the Th1/Th2 dichotomy in different directions. Eur J Immunol 31: 265-275.
53. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE, (2008) Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 83: 64-70.
54. Muller I, Munder M, Kropf P, Hansch GM, (2009) Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends Immunol 30: 522-530.
55. Joos C, Marrama L, Polson HE, Corre S, Diatta AM, et al. (2010) Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies. PLoS One 5: e9871.
56. Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, et al. (2009) T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31: 787-798.
57. Mitsdoerffer M, Lee Y, Jager A, Kim HJ, Korn T, et al. (2010) Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A 107: 14292-14297.
58. Kotner J, Tarleton R, (2007) Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Infect Immun 75: 861-869.
59. Sales PA Jr, Golgher D, Oliveira RV, Vieira V, Arantes RM, et al. (2008) The regulatory CD4+CD25+ T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi. Microbes Infect 10: 680-688.
60. Gabrilovich DI, Nagaraj S, (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174.
61. Zhang X, Majlessi L, Deriaud E, Leclerc C, Lo-Man R, (2009) Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity 31: 761-771.
62. De Santo C, Arscott R, Booth S, Karydis I, Jones M, et al. (2010) Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat Immunol 11: 1039-1046.
63. Bouabe H, Liu Y, Moser M, Bosl MR, Heesemann J, (2011) Novel highly sensitive IL-10-beta-lactamase reporter mouse reveals cells of the innate immune system as a substantial source of IL-10 in vivo. J Immunol 187: 3165-3176.
64. Kayama H, Takeda K, (2010) The innate immune response to Trypanosoma cruzi infection. Microbes Infect 12: 511-517.
65. Ferreira LR, Silva AM, Michailowsky V, Reis LF, Gazzinelli RT, (1999) Expression of serum amyloid A3 mRNA by inflammatory macrophages exposed to membrane glycoconjugates from Trypanosoma cruzi. J Leukoc Biol 66: 593-600.
66. Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H, et al. (2007) IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 178: 3786-3796.
67. Souza DG, Cara DC, Cassali GD, Coutinho SF, Silveira MR, et al. (2000) Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat. Br J Pharmacol 131: 1800-1808.